The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: A meta-analysis of prospective cohort studies

International Journal of Gynecological Cancer

Volumn 23, Issue 2, 2013, Pages 294-303

  Zhang, Zhi Hua ^a   Su, Pu Yu ^a   Hao, Jia Hu ^a   Sun, Ye Huan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cohort study; Diabetes mellitus; Endometrial cancer; Incidence; Meta analysis; Mortality

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84876227957     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31827b8430     Document Type: Article

References (30)

1. Leslie KK, Thiel KW, Goodheart MJ, et al. Endometrial cancer. Obstet Gynecol Clin North Am. 2012;39:255-268.
2. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.
3. Terry P, Baron JA, Weiderpass E, et al. Lifestyle and endometrial cancer risk: A cohort study from the Swedish Twin Registry. Int J Cancer. 1999;82:38-42.
4. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311-321.
5. Jiang Y, Ben Q, Shen H, et al. Diabetes mellitus and incidence and mortality of colorectal cancer: A systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011;26:863-876.
6. Yang WS, Va P, Bray F, et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: A meta-analysis of prospective cohort studies. PLoS One. 2011;6:e27326.
7. Larsson SC, Wolk A. Diabetes mellitus and incidence of kidney cancer: A meta-analysis of cohort studies. Diabetologia. 2011;54:1013-1018.
8. Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011;47:1928-1937.
9. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA. 2008;300:2754-2764.
10. Frasca F, Pandini G, Sciacca L, et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008;114:23-37.
11. Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des. 2007;13:671-686.
12. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia. 2007;50:1365-1374.
13. Lindemann K, Vatten LJ, Ellstrom-Engh M, et al. Body mass, diabetes and smoking, and endometrial cancer risk: A follow-up study. Br J Cancer. 2008;98: 1582-1585.
14. Ogunleye AA, Ogston SA, Morris AD, et al. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer. 2009;101:1199-1201.
15. Johnson JA, Bowker SL, Richardson K, et al. Time-varying incidence of cancer after the onset of type 2 diabetes: Evidence of potential detection bias. Diabetologia. 2011;54:2263-2271.
16. Lambe M, Wigertz A, Garmo H, et al. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control. 2011;22: 1163-1171.
17. Carstensen B, Witte DR, Friis S. Cancer occurrence in Danish diabetic patients: Duration and insulin effects. Diabetologia. 2012;55:948-958.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
19. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
20. Anderson KE, Anderson E, Mink PJ, et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev. 2001;10:611-616.
21. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: A population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2007;16:276-280.
22. Folsom AR, Anderson KE, Sweeney C, et al. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 2004;94:740-745.
23. Coughlin SS, Calle EE, Teras LR, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159: 1160-1167.
24. Khan M, Mori M, Sakauchi F, et al. Risk of endometrial cancer mortality by ever-use of sex hormones and other factors in Japan. Asian Pac J Cancer Prev. 2006;7:260-266.
25. Ragozzino M, Melton LJ 3rd, Chu CP, et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35:13-19.
26. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991;2:307-314.
27. Weiderpass E, Gridley G, Persson I, et al. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer. 1997;71:360-363.
28. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360-1365.
29. Zendehdel K, Nyren O, Ostenson CG, et al. Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J Natl Cancer Inst. 2003;95:1797-1800.
30. Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study. Br J Cancer. 2005;92: 2070-2075.